Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Hemorrhagic Fever Global Clinical Trials Review, H2, 2014

Published: Nov-2014 | Format: PDF | GlobalData | Number of pages: 59 | Code: MRS - 2045

 

GlobalData's clinical trial report, “Hemorrhagic Fever Global Clinical Trials Review, H2, 2014"" provides data on the Hemorrhagic Fever clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemorrhagic Fever. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemorrhagic Fever. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

Scope

 

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)

 

Reasons to buy

 

Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
 

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Hemorrhagic Fever 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Hemorrhagic Fever 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Hemorrhagic Fever Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Sanofi 30
Clinical Trial Overview of Sanofi 30
Sarepta Therapeutics, Inc. 31
Clinical Trial Overview of Sarepta Therapeutics, Inc. 31
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
Liaoning Cheng Da Biotechnology Co., Ltd 33
Clinical Trial Overview of Liaoning Cheng Da Biotechnology Co., Ltd 33
Clinical Trial Overview of Top Institutes / Government 34
U.S. Army Medical Research and Materiel Command 34
Clinical Trial Overview of U.S. Army Medical Research and Materiel Command 34
The National Institute of Allergy and Infectious Diseases 35
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 35
University of Maryland 36
Clinical Trial Overview of University of Maryland 36
Five Key Clinical Profiles 37

 

Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 59"

 

List of Tables
 

Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Region, 2014* 6
Hemorrhagic Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hemorrhagic Fever Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Hemorrhagic Fever Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Hemorrhagic Fever Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Hemorrhagic Fever Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Hemorrhagic Fever Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Hemorrhagic Fever Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Hemorrhagic Fever Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Hemorrhagic Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 30
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarepta Therapeutics, Inc., 2014* 31
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 32
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Liaoning Cheng Da Biotechnology Co., Ltd, 2014* 33
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical Research and Materiel Command, 2014* 34
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 35
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland, 2014* 36

 

List of Figures
 

Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Hemorrhagic Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hemorrhagic Fever Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Hemorrhagic Fever Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 13
Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Hemorrhagic Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 58

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing